A Trial of Lenvatinib (E7080) in Radioiodine (131 I)-Refractory Differentiated Thyroid Cancer in China
Clinical trial NCT02966093 · COMPLETED
Trial details
- NCT number
- NCT02966093
- Sponsor
- Eisai Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2017-01-11
- Primary completion
- 2019-07-31
- Enrollment
- 151
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.